We reported a case of Miller Fisher syndrome following a breakthrough varicella zoster virus infection in an otherwise healthy 6-year-old male. The objective of this review was to summarize the infectious etiologic agents known to trigger Miller Fisher syndrome.
Methods:
Review of the literature on infections associated with Miller Fisher syndrome.
Results:
We identified 762 studies after duplicates were removed. Titles, abstracts, and full texts were screened. Finally, 37 studies were included in qualitative synthesis after citations and reference list were checked. The age range of cases reported was 0-78 years, and male sex was predominant in studies where these parameters were reported. The most common causative agent was Campylobacter jejuni followed by Haemophilus influenzae.
Conclusions:
Our review highlights the importance of recognizing the infections triggering Miller Fisher syndrome. We also present a unique case of Miller Fisher syndrome associated with breakthrough varicella zoster virus infection. Preventive policies may consider population immunization for certain causative agents.
YukiN.Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes. Lancet Infect Dis. 2001;1:29–37.
2.
Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology. Guillain-Barre syndrome variants in Emilia-Romagna, Italy, 1992-3: incidence, clinical features, and prognosis. J Neurol Neurosurg Psychiatry. 1998;65:218–224.
3.
ChibaAKusunokiSShimizuTKanazawaI. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol. 1992;31:677–679.
4.
KogaMYukiNTakahashiMSaitoKHirataK. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain–Barré and Fisher’s syndromes. J Neuroimmunol. 1998;81:138–143.
5.
KogaMYukiNTaiTHirataK. Miller Fisher syndrome and Haemophilus influenzae infection. Neurology. 2001;57:686–691.
6.
RizzoACUliviMBrunelliN, et al.A case of miller fisher syndrome associated with preceding herpes zoster ophthalmicus. Muscle Nerve. 2017;55:E15–E16.
7.
TakanoHYukiN. Fisher’s syndrome associated with chickenpox and anti-GQ1b antibody. J Neurol. 1995;242:255–256.
8.
UematsuDSatohTTanahashiNKotoAGotohF. Fisher’s syndrome following trigeminal herpes zoster. Eur Neurol. 1985;24:314–318.
9.
TakahashiMKogaMYokoyamaKYukiN. Epidemiology of Campylobacter jejuni isolated from patients with Guillain-Barre and Fisher syndromes in Japan. J Clin Microbiol. 2005;43:335–339.
10.
UenoTKonTKuriharaATomiyamaM. Unilateral oculomotor nerve palsy following campylobacter infection: a mild form of Miller Fisher syndrome without ataxia. Intern Med. 2017;56:2929–2932.
11.
SallowaySMermelLASeamansM, et al.Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3. Infect Immun. 1996;64:2945–2949.
12.
NeisserABernheimerHBergerTMoranAPSchwererB. Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome. Infect Immun. 1997;65:4038–4042.
13.
JacobsBCEndtzHPvan der MechéFGHazenbergMPAchtereekteHAvan DoornPA. Serum anti-GQ1bIgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome. Ann Neurol. 1995;37:260–264.
14.
KogaMYukiNKashiwaseKTadokoroKJujiTHirataK. Guillain–Barré and Fisher’s syndromes subsequent to Campylobacter jejuni enteritis are associated with HLA-B54 and Cw1 independent of anti-ganglioside antibodies. J Neuroimmunol. 1998;88:62–66.
15.
LeeKY. Anti-GQ1b-negative Miller Fisher syndrome after Campylobacter jejuni enteritis. Pediatr Neurol. 2012;47:213–215.
16.
ShinJEAcklooSMainkarASMonteiroMAPangHPennerJLAspinallGO. Lipo-oligosaccharides of Campylobacter jejuni serotype O:10. Structures of core oligosaccharide regions from a bacterial isolate from a patient with the Miller-Fisher syndrome and from the serotype reference strain. Carbohydr Res. 1997;305:223–232.
17.
OhtsukaKNakamuraYHashimotoM, et al.Fisher syndrome associated with IgG anti-GQ1b antibody following infection by a specific serotype of Campylobacter jejuni. Ophthalmology. 1998;105:1281–1285.
RobertsTShahAGrahamJGMcQueenIN. The Miller Fisher syndrome following campylobacter enteritis: a report of two cases. J Neurol Neurosurg Psychiatry. 1987;50:1557–1518.
20.
HoulistonRSKogaMLiJ, et al.A Haemophilus influenzae strain associated with Fisher Syndrome expresses a novel desialylated ganglioside mimic. Biochemistry. 2007;46:8164–8171.
21.
CostiniukCTLe SauxNSellE, et al.Miller Fisher syndrome in a toddler with influenza A (pH1N1) infection. J Child Neurol. 2010;26:385–388.
22.
HaraMMoritaAIchiharaK, et al.Miller Fisher syndrome associated with influenza A Infection. Int Med. 2012;51:2621–2123.
23.
LeeSYLeeYHChunBY, et al.An adult case of Fisher syndrome subsequent to Mycoplasma pneumoniae infection. J Korean Med Sci. 2013;28:152–155.
24.
MerkxHDe KeyserJEbingerG. Miller Fisher syndrome associated with Mycoplasma pneumoniae infection: report of a case. Clin Neurol Neurosurg. 1994;96:96–99.
25.
ShimizuTTokudaY. Miller Fisher syndrome linked to Norovirus infection. BMJ Case Rep. 2012;2012:bcr2012007776.
26.
BennettoLPLyonsP. Miller Fisher syndrome associated with Pasteurella multocida infection. J Neurol Neurosurg Psychiatry. 2004;75:1786–1787.
27.
BlasettiACerrutoMCutarellaR, et al.Miller Fisher syndrome and Escherichia coli infection: is it a novel association?J Child Neurol. 2007;22:71–73.
28.
ChibaSSugiyamaTYonekuraK, et al.An antibody to VacA of Helicobacter pylori in the CSF of patients with Miller-Fisher syndrome. Neurology. 2004;63:2184–2186.
29.
CommunalCFilleronABaron-JolySSaletRTranTA. Pediatric Miller Fisher syndrome complicating an Epstein–Barr virus infection. Pediatr Neurol.2016;63:73–75.
30.
SlavickHEShapiroRA. Fisher’s syndrome associated with Epstein-Barr virus. Arc Neurol. 1981;38:134–135.
31.
IshikawaHWakakuraMIshikawaS. Enhanced ptosis in Fisher’s syndrome after Epstein-Barr virus infection. J Clin Neuroophthalmol. 1990;10:197–200.
32.
FukaeJTsugawaJOumaSUmezuTKusunokiSTsuboiY. Guillain–Barré and Miller Fisher syndromes in patients with anti-hepatitis E virus antibody: a hospital-based survey in Japan. Neurol Sci. 2016;37:1849–1851.
Sillevis SmittPAPortegiesP. Fisher’s syndrome associated with human immunodeficiency virus infection. Clin Neurol Neurosurg. 1990;92:353–355.
35.
KimKWKimYHKimBH, et al.Miller Fisher syndrome related to Orientia tsutsugamushi infection. J Clin Neurosci. 2014;21:2251–222.
36.
MoustakiMGikaAFretzayasAVoutsiotiAYiallourosPKarpathiosT. Miller-Fisher syndrome in association with enterovirus infection. J Child Neurol. 2012;27:521–522.
37.
VergoriAMasiGDonatiD, et al.Listeria meningoencephalitis and anti-GQ1b antibody syndrome. Infection. 2016;44:543–546.
38.
YukiNHirataK. Fisher’s syndrome and group A streptococcal infection. J Neurol Sci. 1998;160:64–66.
39.
MunsatTLBarnesJE. Relation of multiple cranial nerve dysfunction to the Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 1965;28:115–120.
40.
Diaz OrtunoAMaeztuCMunozJAReigadasRRodriguezTValdesM. Miller Fisher syndrome associated with Q fever. J Neurol Neurosurg Psychiatry. 1990;53:615–616.
41.
KogaMGilbertMLiJ, et al.Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Neurology. 2005;64:1605–1611.
42.
JacobsBCRothbarthPHvan der MecheFG, et al.The spectrum of antecedent infections in Guillain-Barre syndrome: a case-control study. Neurology. 1998;51:1110–1115.
43.
KurokiSSaidaTNukinaM, et al.Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain β-N-acetylglucosamine residues. Ann Neurol. 1993;33:243–247.
44.
ReesJHSoudainSEGregsonNAHughesRA. Campylobacter jejuni infection and Guillain–Barré syndrome. N Engl J Med. 1995;333:1374–1379.
45.
RileyHDCramblettHG. Hemophilus influenzae infections: part I. CRC Crit Rev Clin Lab Sci. 1981;15:231–275.
46.
WaitesKBTalkingtonDF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17:697–728.
ArvinAM.Varicella-zoster virus. In: Principles and Practice of Pediatric Infectious Diseases. Philadelphia, PA: Elsevier; 2018:1065–1073.
50.
BerlitPRakickyJ.The Miller Fisher syndrome. Review of the literature. J Clin NeuroOphthalmol. 1992;12:57–63.
51.
Moreno-AjonaDIrimiaPFernández-MatarrubiaM. Headache and ophthalmoparesis: case report of an “atypical” incomplete Miller-Fisher syndrome. Headache. 2018;58:746–749.
52.
MalhotraAZhangMWuXJindalSDurandDMakhaniN. MRI findings of optic pathway involvement in Miller Fisher syndrome in 3 pediatric patients and a review of the literature. J Clin Neurosci. 2017;39:63–67.
53.
ItoMKuwabaraSOdakaM, et al.Bickerstaff’s brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases. J Neurol. 2008;255(5):674–682.
54.
AranyiZKovacsTSiposIBereczkiD. Miller Fisher syndrome: brief overview and update with a focus on electrophysiological findings. Eur J Neurol. 2012;19(1):15–20, e1-e3.
55.
HattoriMTakadaKYamadaK, et al.A case of Miller Fisher syndrome with gadolinium-enhancing lesions in the cranial nerves and the cauda equina on magnetic resonance imaging. Rinsho Shinkeigaku. 1999;39(10):1054–1058.
56.
GiannaulaRJSeijasMBNúñezDA, et al.3-25-07 Miller Fisher-Guillain-Barré overlap syndrome with brainstem pathological MRI findings. J Neurol Sci. 1997;150(suppl 1):S177.
57.
Garcia-RiveraCARozenTDZhouD, et al.Miller Fisher syndrome: MRI findings. Neurology. 2001;57(10):1755.
58.
YikilmazADoganaySGumusH, et al.Magnetic resonance imaging of childhood Guillain-Barre syndrome. Childs Nerv Syst. 2010;26(8):1103–1108.
59.
NagaokaUKatoTKuritaK. Cranial nerve enhancement on three-dimensional MRI in Miller Fisher syndrome. Neurology. 1996;47(6):1601–1602.
60.
ZuccoliGPanigrahyABaileyA, et al.Redefining the Guillain-Barre spectrum in children: neuroimaging findings of cranial nerve involvement. AJNR Am J Neuroradiol. 2011;32(4):639–642.
61.
Colding-JorgensenEVissingJ. Visual impairment in anti-GQ1b positive Miller Fisher syndrome. Acta Neurol Scand. 2001;103:259–260.
62.
RamakrishmanSKulkamiGBMustareV. Neuro-ophthalmological manifestations in three cases of Miller Fisher syndrome and a brief report of the literature. Neurol India. 2015;63:975–977.
63.
LorussoFCalecaMPBellaviaC, et al.The EBV-DNA can be used as a diagnostic and follow-up parameter of the rhinopharyngeal tumors in the non-endemic population of the Western Sicily. Olaryngol Head Neck Surg. 2019;71:396–400.
